Daliresp Interactions
There are 362 drugs known to interact with Daliresp (roflumilast), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 3 are major, 356 are moderate, and 3 are minor.
- View all 362 medications that may interact with Daliresp
- View Daliresp alcohol/food interactions (1)
- View Daliresp disease interactions (3)
Most frequently checked interactions
View interaction reports for Daliresp (roflumilast) and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- albuterol / ipratropium
- alprazolam
- amlodipine
- aspirin
- atorvastatin
- azithromycin
- furosemide
- gabapentin
- Lasix (furosemide)
- levothyroxine
- lisinopril
- losartan
- metformin
- metoprolol
- montelukast
- Mucinex (guaifenesin)
- omeprazole
- pantoprazole
- potassium chloride
- prednisone
- ProAir HFA (albuterol)
- Singulair (montelukast)
- Spiriva (tiotropium)
- Symbicort (budesonide / formoterol)
- tramadol
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Ventolin HFA (albuterol)
- Vitamin D3 (cholecalciferol)
Daliresp alcohol/food interactions
There is 1 alcohol/food interaction with Daliresp (roflumilast).
Daliresp disease interactions
There are 3 disease interactions with Daliresp (roflumilast) which include:
Report options
QR code containing a link to this page
More about Daliresp (roflumilast)
- Daliresp consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (63)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: selective phosphodiesterase-4 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
